Nitric oxide-induced neuronal to glial lineage fate-change depends on NRSF/REST function in neural progenitor cells

Stem Cells

Volumn 32, Issue 9, 2014, Pages 2539-2549

  Bergsland, Maria ^a   Covacu, Ruxandra ^a   Perez Estrada, Cynthia ^a   Svensson, Mikael ^a   Brundin, Lou ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Differentiation; Neural stem cells; Oligodendrocytes; Stem cell microenvironment interactions; Transcription factors

Indexed keywords

NEURON RESTRICTIVE SILENCING FACTOR 1; NITRIC OXIDE; REPRESSOR ELEMENT 1 SILENCING TRANSCRIPTION; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ACETYLATION; ADULT; ANIMAL CELL; ARTICLE; ASTROCYTE; CELL CULTURE; CELL DEATH; CELL DIFFERENTIATION; CELL FATE; CELL LINEAGE; CHROMATIN; CONTROLLED STUDY; DNA BINDING; EXPRESSION VECTOR; GENE EXPRESSION; GENE REPRESSION; GENETIC TRANSFECTION; GLIA CELL; HISTONE MODIFICATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; METHYLATION; NERVE CELL; NERVE CELL DIFFERENTIATION; NEURAL STEM CELL; NICK END LABELING; NONHUMAN; OLIGODENDROGLIA; PREMATURITY; PROMOTER REGION; PROTEIN FUNCTION; RAT; SILENT GENE; UPREGULATION; WESTERN BLOTTING; ZINC FINGER MOTIF; ANIMAL; CYTOLOGY; GLIA; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CELL DIFFERENTIATION; HUMANS; NEURAL STEM CELLS; NEUROGLIA; NEURONS; NITRIC OXIDE; OLIGODENDROGLIA; RATS; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 84906272839     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.1749     Document Type: Article

References (55)

1. Sequerra EB, Costa MR, Menezes JR, et al. Adult neural stem cells: Plastic or restricted neuronal fates? Development 2013; 140: 3303-3309.
2. Ernst A, Alkass K, Bernard S, et al. Neurogenesis in the striatum of the adult human brain. Cell 2014; 156: 1072-1083.
3. Curtis MA, Low VF, Faull RL,. Neurogenesis and progenitor cells in the adult human brain: A comparison between hippocampal and subventricular progenitor proliferation. Dev Neurobiol 2012; 72: 990-1005.
4. Kohman RA, Rhodes JS,. Neurogenesis, inflammation and behavior. Brain Behav Immun 2013; 27: 22-32.
5. Iliff JJ, Wang M, Liao Y, et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta. Sci Transl Med 2012; 4: 147ra111.
6. Garthwaite J,. Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci 1991; 14: 60-67.
7. Packer MA, Stasiv Y, Benraiss A, et al. Nitric oxide negatively regulates mammalian adult neurogenesis. Proc Natl Acad Sci USA 2003; 100: 9566-9571.
8. Moncada S, Palmer RM, Higgs EA,. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 109-142.
9. Salter M, Knowles RG, Moncada S,. Widespread tissue distribution, species distribution and changes in activity of Ca(2+)-dependent and Ca(2+)-independent nitric oxide synthases. FEBS Lett 1991; 291: 145-149.
10. Forstermann U, Boissel JP, Kleinert H,. Expressional control of the 'constitutive' isoforms of nitric oxide synthase (NOS I and NOS III). FASEB J 1998; 12: 773-790.
11. Bolli R, Dawn B, Xuan YT,. Role of the JAK-STAT pathway in protection against myocardial ischemia/reperfusion injury. Trends Cardiovasc Med 2003; 13: 72-79.
12. Nathan CF, Hibbs JB, Jr,. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol 1991; 3: 65-70.
13. Amber IJ, Hibbs JB, Jr,., Taintor RR, et al. The L-arginine dependent effector mechanism is induced in murine adenocarcinoma cells by culture supernatant from cytotoxic activated macrophages. J Leukoc Biol 1988; 43: 187-192.
14. Chao CC, Hu S,. Tumor necrosis factor-alpha potentiates glutamate neurotoxicity in human fetal brain cell cultures. Dev Neurosci 1994; 16: 172-179.
15. Merrill JE, Ignarro LJ, Sherman MP, et al. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J Immunol 1993; 151: 2132-2141.
16. Visser JJ, Scholten RJ, Hoekman K,. Nitric oxide synthesis in meningococcal meningitis. Ann Intern Med 1994; 120: 345-346.
17. Brundin L, Svenungsson E, Morcos E, et al. Central nervous system nitric oxide formation in cerebral systemic lupus erythematosus. Ann Neurol 1998; 44: 704-706.
18. Taskiran D, Sagduyu A, Yuceyar N, et al. Increased cerebrospinal fluid and serum nitrite and nitrate levels in amyotrophic lateral sclerosis. Int J Neurosci 2000; 101: 65-72.
19. Danilov AI, Andersson M, Bavand N, et al. Nitric oxide metabolite determinations reveal continuous inflammation in multiple sclerosis. J Neuroimmunol 2003; 136: 112-118.
20. Lynch DR, Dawson TM,. Secondary mechanisms in neuronal trauma. Curr Opin Neurol 1994; 7: 510-516.
21. Bo L, Dawson TM, Wesselingh S, et al. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann Neurol 1994; 36: 778-786.
22. Svenningsson A, Petersson AS, Andersen O, et al. Nitric oxide metabolites in CSF of patients with MS are related to clinical disease course. Neurology 1999; 53: 1880-1882.
23. Covacu R, Danilov AI, Rasmussen BS, et al. Nitric oxide exposure diverts neural stem cell fate from neurogenesis towards astrogliogenesis. Stem Cells 2006; 24: 2792-2800.
24. Chen ZF, Paquette AJ, Anderson DJ,. NRSF/REST is required in vivo for repression of multiple neuronal target genes during embryogenesis. Nat Genet 1998; 20: 136-142.
25. Schoenherr CJ, Anderson DJ,. The neuron-restrictive silencer factor (NRSF): A coordinate repressor of multiple neuron-specific genes. Science 1995; 267: 1360-1363.
26. Ballas N, Mandel G,. The many faces of REST oversee epigenetic programming of neuronal genes. Curr Opin Neurobiol 2005; 15: 500-506.
27. Dewald LE, Rodriguez JP, Levine JM,. The RE1 binding protein REST regulates oligodendrocyte differentiation. J Neurosci 2011; 31: 3470-3483.
28. Covey MV, Streb JW, Spektor R, et al. REST regulates the pool size of the different neural lineages by restricting the generation of neurons and oligodendrocytes from neural stem/progenitor cells. Development 2012; 139: 2878-2890.
29. Zheng D, Zhao K, Mehler MF,. Profiling RE1/REST-mediated histone modifications in the human genome. Genome Biol 2009; 10: R9.
30. Dietrich N, Lerdrup M, Landt E, et al. REST-mediated recruitment of polycomb repressor complexes in mammalian cells. PLoS Genet 2012; 8: e1002494.
31. Bergsland M, Werme M, Malewicz M, et al. The establishment of neuronal properties is controlled by Sox4 and Sox11. Genes Dev 2006; 20: 3475-3486.
32. Westerlund U, Moe MC, Varghese M, et al. Stem cells from the adult human brain develop into functional neurons in culture. Exp Cell Res 2003; 289: 378-383.
33. Bergsland M, Ramskold D, Zaouter C, et al. Sequentially acting Sox transcription factors in neural lineage development. Genes Dev 2011; 25: 2453-2464.
34. Mehler MF,. Mechanisms regulating lineage diversity during mammalian cerebral cortical neurogenesis and gliogenesis. Results Probl Cell Differ 2002; 39: 27-52.
35. Stolt CC, Lommes P, Sock E, et al. The Sox9 transcription factor determines glial fate choice in the developing spinal cord. Genes Dev 2003; 17: 1677-1689.
36. Sugimori M, Nagao M, Bertrand N, et al. Combinatorial actions of patterning and HLH transcription factors in the spatiotemporal control of neurogenesis and gliogenesis in the developing spinal cord. Development 2007; 134: 1617-1629.
37. Roybon L, Deierborg T, Brundin P, et al. Involvement of Ngn2, Tbr and NeuroD proteins during postnatal olfactory bulb neurogenesis. Eur J Neurosci 2009; 29: 232-243.
38. Johnson R, Teh CH, Kunarso G, et al. REST regulates distinct transcriptional networks in embryonic and neural stem cells. PLoS Biol 2008; 6: e256.
39. Gao Z, Ure K, Ding P, et al. The master negative regulator REST/NRSF controls adult neurogenesis by restraining the neurogenic program in quiescent stem cells. J Neurosci 2011; 31: 9772-9786.
40. Hawkins RD, Hon GC, Yang C, et al. Dynamic chromatin states in human ES cells reveal potential regulatory sequences and genes involved in pluripotency. Cell Res 2011; 21: 1393-1409.
41. Tie F, Banerjee R, Stratton CA, et al. CBP-mediated acetylation of histone H3 lysine 27 antagonizes Drosophila Polycomb silencing. Development 2009; 136: 3131-3141.
42. Brundin L, Morcos E, Olsson T, et al. Increased intrathecal nitric oxide formation in multiple sclerosis; cerebrospinal fluid nitrite as activity marker. Eur J Neurol 1999; 6: 585-590.
43. Gahm C, Danilov A, Holmin S, et al. Reduced neuronal injury after treatment with NG-nitro-L-arginine methyl ester (L-NAME) or 2-sulfo-phenyl-N- tert-butyl nitrone (S-PBN) following experimental brain contusion. Neurosurgery 2005; 57: 1272-1281; discussion 1272-1281.
44. Raine CS, Cross AH,. Axonal dystrophy as a consequence of long-term demyelination. Lab Invest 1989; 60: 714-725.
45. Pekny M, Johansson CB, Eliasson C, et al. Abnormal reaction to central nervous system injury in mice lacking glial fibrillary acidic protein and vimentin. J Cell Biol 1999; 145: 503-514.
46. Sabelstrom H, Stenudd M, Reu P, et al. Resident neural stem cells restrict tissue damage and neuronal loss after spinal cord injury in mice. Science 2013; 342: 637-640.
47. Barnabe-Heider F, Goritz C, Sabelstrom H, et al. Origin of new glial cells in intact and injured adult spinal cord. Cell Stem Cell 2010; 7: 470-482.
48. Moll NM, Hong E, Fauveau M, et al. SOX17 is expressed in regenerating oligodendrocytes in experimental models of demyelination and in multiple sclerosis. Glia 2013; 61: 1659-1672.
49. Pfeifenbring S, Metz I, Kremer D, et al. Oligodendroglial lineage cells express nuclear p57kip2 in multiple sclerosis lesions. Glia 2013; 61: 1250-1260.
50. Mecha M, Feliu A, Carrillo-Salinas FJ, et al. Mobilization of progenitors in the subventricular zone to undergo oligodendrogenesis in the Theiler's virus model of multiple sclerosis: Implications for remyelination at lesions sites. Exp Neurol 2013; 250C: 348-352.
51. Nait-Oumesmar B, Picard-Riera N, Kerninon C, et al. The role of SVZ-derived neural precursors in demyelinating diseases: From animal models to multiple sclerosis. J Neurol Sci 2008; 265: 26-31.
52. Tepavcevic V, Lazarini F, Alfaro-Cervello C, et al. Inflammation-induced subventricular zone dysfunction leads to olfactory deficits in a targeted mouse model of multiple sclerosis. J Clin Invest 2011; 121: 4722-4734.
53. Conaco C, Otto S, Han JJ, et al. Reciprocal actions of REST and a microRNA promote neuronal identity. Proc Natl Acad Sci USA 2006; 103: 2422-2427.
54. Cheng LC, Pastrana E, Tavazoie M, et al. miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche. Nat Neurosci 2009; 12: 399-408.
55. Mortazavi A, Leeper Thompson EC, Garcia ST, et al. Comparative genomics modeling of the NRSF/REST repressor network: From single conserved sites to genome-wide repertoire. Genome Res 2006; 16: 1208-1221.